Longitudinal changes in blood-based biomarkers in chronic moderate to severe traumatic brain injury: preliminary findings

2Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives: This longitudinal study aims at 1) providing preliminary evidence of changes in blood-based biomarkers across time in chronic TBI and 2) relating these changes to outcome measures and cerebral structure and activity. Methods: Eight patients with moderate-to-severe TBI (7 males, 35 ± 7.6 years old, 5 severe TBI, 17.52 ± 3.84 months post-injury) were evaluated at monthly intervals across 6 time-points using: a) Blood-based biomarkers (GFAP, NSE, S100A12, SDBP145, UCH-L1, T-tau, P-tau, P-tau/T-tau ratio); b) Magnetic Resonance Imaging to evaluate changes in brain structure; c) Resting-state electroencephalograms to evaluate changes in brain function; and d) Outcome measures to assess cognition, emotion, and functional recovery (MOCA, RBANS, BDI-II, and DRS). Results: Changes in P-tau levels were found across time [p = .007]. P-tau was positively related to functional [p

Cite

CITATION STYLE

APA

Schnakers, C., Divine, J., Johnson, M. A., Lutkenhoff, E., Monti, M. M., Keil, K. M., … Rosario, E. R. (2021). Longitudinal changes in blood-based biomarkers in chronic moderate to severe traumatic brain injury: preliminary findings. Brain Injury, 35(3), 285–291. https://doi.org/10.1080/02699052.2020.1858345

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free